𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia

✍ Scribed by Lalit Saini; Mark D. Minden; Andre C. Schuh; Karen W.L. Yee; Aaron D. Schimmer; Vikas Gupta; Eshetu G. Atenafu; Cindy Murray; Shannon Nixon; Joseph M. Brandwein

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
243 KB
Volume
87
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of remission induction chemothera
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization

An abnormal CD34+ myeloid/CD34+ lymphoid
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia
✍ A. MartΓ­nez; J. F. San Miguel; M.-B. Vidriales; J. Ciudad; M. D. Caballero; M. C πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 2 views

During conventional follow-up of patients with acute myeloid leukemia (AML), the emergence of cytopenias is considered to be a sign of impending relapse, and it represents an example of how leukemic hematopoiesis affects normal hemopoietic differentiation. In the present study, we have explored the

Results of intensive chemotherapy in 998
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: : Predictive prognostic models for outcome
✍ Hagop Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Eli πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Elderly patients (age β‰₯ 65 years) with acute myeloid leukemia (AML) generally have a poor prognosis. AML‐type therapy results are often derived from studies in younger patients and may not apply to elderly AML. Many investigators and oncologists advocate, at times, only s

A randomized, postremission comparison o
A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia : The Japan Adult Leukemia Study Group AML97 study
✍ Shuichi Miyawaki; Hisashi Sakamaki; Shigeki Ohtake; Nobuhiko Emi; Fumiharu Yagas πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 316 KB
A scoring system to predict the risk of
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia
✍ David ValcΓ‘rcel; Pau Montesinos; Isabel SΓ‘nchez-Ortega; Salut Brunet; Jordi Este πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 196 KB πŸ‘ 2 views

## Abstract ## BACKGROUND: A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed. ## METHODS: The authors analyzed 570 patients (aged 16‐70 years) included in 2 multicenter trials of the CETLAM Grou